Pediatric Radiology

, Volume 46, Issue 6, pp 829–837 | Cite as

MR enterography: how to deliver added value

  • Jonathan R. DillmanEmail author
  • Andrew T. Trout
  • Ethan A. Smith
Pediatric Body MRI


MR enterography (MRE) is increasingly vital to the diagnosis and follow-up of children with Crohn disease. This diagnostic test, which can provide valuable information regarding the presence of intestinal inflammation, intestinal and intra-abdominal complications, and extra-intestinal disease-related manifestations, has the potential to directly impact both medical and surgical decision-making. Consequently, it is imperative that the interpretation and reporting of these examinations provide as much clinical information as possible. This article reviews specific ways radiologists can provide added value when interpreting MRE examinations in the setting of pediatric Crohn disease by (1) establishing the true extent of disease involvement, (2) subjectively and objectively assessing response to medical treatment and (3) accurately characterizing disease-related complications.


Children Crohn disease Inflammation Magnetic resonance enterography Magnetic resonance imaging Small bowel 


Compliance with ethical standards

Conflicts of interest

Dr. Dillman receives grant support from Siemens Medical Solutions USA, Inc. Drs. Trout and Smith have no financial interests to disclose. Authors have no investigational or off-label uses to disclose.


  1. 1.
    Day AS, Ledder O, Leach ST et al (2012) Crohn’s and colitis in children and adolescents. World J Gastroenterol 18:5862–5869CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Lovasz BD, Lakatos L, Horvath A et al (2014) Incidence rates and disease course of paediatric inflammatory bowel diseases in Western Hungary between 1977 and 2011. Dig Liver Dis 46:405–411CrossRefPubMedGoogle Scholar
  3. 3.
    Martín-de-Carpi J, Rodríguez A, Ramos E et al (2014) The complete picture of changing pediatric inflammatory bowel disease incidence in Spain in 25 years (1985–2009): the EXPERIENCE registry. J Crohns Colitis 8:763–769CrossRefPubMedGoogle Scholar
  4. 4.
    Lehtinen P, Ashorn M, Iltanen S et al (2011) Incidence trends of pediatric inflammatory bowel disease in Finland, 1987–2003, a nationwide study. Inflamm Bowel Dis 17:1778–1783CrossRefPubMedGoogle Scholar
  5. 5.
    Anupindi SA, Podberesky DJ, Towbin AJ et al (2015) Pediatric inflammatory bowel disease: imaging issues with targeted solutions. Abdom Imaging 40:975–992CrossRefPubMedGoogle Scholar
  6. 6.
    Mollard BJ, Smith EA, Dillman JR (2015) Pediatric MR enterography: technique and approach to interpretation — how we do it. Radiology 274:29–43CrossRefPubMedGoogle Scholar
  7. 7.
    Duigenan S, Gee MS (2012) Imaging of pediatric patients with inflammatory bowel disease. AJR Am J Roentgenol 199:907–915CrossRefPubMedGoogle Scholar
  8. 8.
    Domina JG, Dillman JR, Adler J et al (2013) Imaging trends and radiation exposure in pediatric inflammatory bowel disease at an academic children’s hospital. AJR Am J Roentgenol 201:W133–W140CrossRefPubMedGoogle Scholar
  9. 9.
    (2016) Value added: definition of ‘value added.’ Investopedia. Accessed 12 Jan 2016
  10. 10.
    Samuel S, Bruining DH, Loftus EV Jr et al (2012) Endoscopic skipping of the distal terminal ileum in Crohn’s disease can lead to negative results from ileocolonoscopy. Clin Gastroenterol Hepatol 10:1253–1259CrossRefPubMedGoogle Scholar
  11. 11.
    Lazarev M, Huang C, Bitton A et al (2013) Relationship between proximal Crohn’s disease location and disease behavior and surgery: a cross-sectional study of the IBD Genetics Consortium. Am J Gastroenterol 108:106–112CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Dillman JR, Ladino-Torres MF, Adler J et al (2011) Comparison of MR enterography and histopathology in the evaluation of pediatric Crohn disease. Pediatr Radiol 41:1552–1558CrossRefPubMedGoogle Scholar
  13. 13.
    De Zoeten EF, Pasternak BA, Mattei P et al (2013) Diagnosis and treatment of perianal Crohn disease: NASPGHAN clinical report and consensus statement. J Pediatr Gastroenterol Nutr 57:401–412CrossRefPubMedGoogle Scholar
  14. 14.
    Eglinton TW, Barclay ML, Gearry RB et al (2012) The spectrum of perianal Crohn’s disease in a population-based cohort. Dis Colon Rectum 55:773–777CrossRefPubMedGoogle Scholar
  15. 15.
    Peyrin-Biroulet L, Loftus EV Jr, Tremaine WJ et al (2012) Perianal Crohn’s disease findings other than fistulas in a population-based cohort. Inflamm Bowel Dis 18:43–48CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Tolia V (1996) Perianal Crohn’s disease in children and adolescents. Am J Gastroenterol 91:922–926PubMedGoogle Scholar
  17. 17.
    Markowitz J, Daum F, Aiges H et al (1984) Perianal disease in children and adolescents with Crohn’s disease. Gastroenterology 86:829–833PubMedGoogle Scholar
  18. 18.
    Hammer MR, Dillman JR, Smith EA et al (2013) Magnetic resonance imaging of perianal and perineal Crohn disease in children and adolescents. Magn Reson Imaging Clin N Am 21:813–828CrossRefPubMedGoogle Scholar
  19. 19.
    Essary B, Kim J, Anupindi S et al (2007) Pelvic MRI in children with Crohn disease and suspected perianal involvement. Pediatr Radiol 37:201–208CrossRefPubMedGoogle Scholar
  20. 20.
    O’Malley RB, Al-Hawary MM, Kaza RK et al (2012) Rectal imaging, part 2: perianal fistula evaluation on pelvic MRI — what the radiologist needs to know. AJR Am J Roentgenol 199:W43–W53CrossRefPubMedGoogle Scholar
  21. 21.
    Kotze PG, Albuquerque IC, Moreira Ada L et al (2014) Perianal complete remission with combined therapy (seton placement and anti-TNF agents) in Crohn’s disease: a Brazilian multicenter observational study. Arq Gastroenterol 51:284–289CrossRefPubMedGoogle Scholar
  22. 22.
    Sauk J, Nguyen D, Yajnik V et al (2014) Natural history of perianal Crohn’s disease after fecal diversion. Inflamm Bowel Dis 20:2260–2265CrossRefPubMedGoogle Scholar
  23. 23.
    Regueiro M, Mardini H (2003) Treatment of perianal fistulizing Crohn’s disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement. Inflamm Bowel Dis 9:98–103CrossRefPubMedGoogle Scholar
  24. 24.
    Short SS, Dubinsky MC, Rabizadeh S et al (2013) Distinct phenotypes of children with perianal perforating Crohn’s disease. J Pediatr Surg 48:1301–1305CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Smith EA, Dillman JR, Adler J et al (2012) MR enterography of extraluminal manifestations of inflammatory bowel disease in children and adolescents: moving beyond the bowel wall. AJR Am J Roentgenol 198:W38–W45CrossRefPubMedGoogle Scholar
  26. 26.
    Hill GL, Mair WS, Goligher JC (1975) Gallstones after ileostomy and ileal resection. Gut 16:932–936CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Jasdanwala S, Babyatsky M (2015) Crohn’s disease and acute pancreatitis. A review of literature. JOP 16:136–142PubMedGoogle Scholar
  28. 28.
    Martinelli M, Strisciuglio C, Illiceto MT et al (2015) Natural history of pancreatic involvement in paediatric inflammatory bowel disease. Dig Liver Dis 47:384–389CrossRefPubMedGoogle Scholar
  29. 29.
    Yi GC, Yoon KH, Hwang JB (2012) Acute pancreatitis induced by azathioprine and 6-mercaptopurine proven by single and low dose challenge testing in a child with Crohn disease. Pediatr Gastroenterol Hepatol Nutr 15:272–275CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Macfarlane PI, Miller V, Wells F et al (1986) Laboratory assessment of disease activity in childhood Crohn’s disease and ulcerative colitis. J Pediatr Gastroenterol Nutr 5:93–96CrossRefPubMedGoogle Scholar
  31. 31.
    Cellier C, Sahmoud T, Froguel E et al (1994) Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn’s disease. A prospective multicentre study of 121 cases. The Groupe d’Etudes Thérapeutiques des Affections Inflammatoires Digestives. Gut 35:231–235CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Oliva-Hemker M, Hutfless S, Al Kazzi ES et al (2015) Clinical presentation and five-year therapeutic management of very early-onset inflammatory bowel disease in a large North American cohort. J Pediatr 167:527–532CrossRefPubMedGoogle Scholar
  33. 33.
    Baker ME, Hara AK, Platt JF et al (2015) CT enterography for Crohn’s disease: optimal technique and imaging issues. Abdom Imaging 40:938–952CrossRefPubMedGoogle Scholar
  34. 34.
    Rimola J, Ordás I, Rodriguez S et al (2011) Magnetic resonance imaging for evaluation of Crohn’s disease: validation of parameters of severity and quantitative index of activity. Inflamm Bowel Dis 17:1759–1768CrossRefPubMedGoogle Scholar
  35. 35.
    Ordás I, Rimola J, Rodríguez S et al (2014) Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn’s disease. Gastroenterology 146:374–382CrossRefPubMedGoogle Scholar
  36. 36.
    Caruso A, D’Incà R, Scarpa M et al (2014) Diffusion-weighted magnetic resonance for assessing ileal Crohn’s disease activity. Inflamm Bowel Dis 20:1575–1583CrossRefPubMedGoogle Scholar
  37. 37.
    Hordonneau C, Buisson A, Scanzi J et al (2014) Diffusion-weighted magnetic resonance imaging in ileocolonic Crohn’s disease: validation of quantitative index of activity. Am J Gastroenterol 109:89–98CrossRefPubMedGoogle Scholar
  38. 38.
    Ream JM, Dillman JR, Adler J et al (2013) MRI diffusion-weighted imaging (DWI) in pediatric small bowel Crohn disease: correlation with MRI findings of active bowel wall inflammation. Pediatr Radiol 43:1077–1085CrossRefPubMedGoogle Scholar
  39. 39.
    Rosenbaum DG, Rose ML, Solomon AB et al (2015) Longitudinal diffusion-weighted imaging changes in children with small bowel Crohn’s disease: preliminary experience. Abdom Imaging 40:1075–1080CrossRefPubMedGoogle Scholar
  40. 40.
    Amitai MM, Raviv-Zilka L, Hertz M et al (2015) Main imaging features of Crohn’s disease: agreement between MR-enterography and CT-enterography. Isr Med Assoc J 17:293–297PubMedGoogle Scholar
  41. 41.
    Cullen G, Vaughn B, Ahmed A et al (2012) Abdominal phlegmons in Crohn’s disease: outcomes following antitumor necrosis factor therapy. Inflamm Bowel Dis 18:691–696CrossRefPubMedGoogle Scholar
  42. 42.
    Adler J, Swanson SD, Schmiedlin-Ren P et al (2011) Magnetization transfer helps detect intestinal fibrosis in an animal model of Crohn disease. Radiology 259:127–135CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Rimola J, Planell N, Rodríguez S et al (2015) Characterization of inflammation and fibrosis in Crohn’s disease lesions by magnetic resonance imaging. Am J Gastroenterol 110:432–440CrossRefPubMedGoogle Scholar
  44. 44.
    Barkmeier DT, Dillman JR, Al-Hawary M et al (2015) MR enterography-histology comparison in pediatric small bowel strictures: can imaging predict fibrosis? Pediatr Radiol. doi:  10.1007/s00247-015-3506-6
  45. 45.
    Dillman JR, Swanson SD, Johnson LA et al (2015) Comparison of noncontrast MRI magnetization transfer and T2-weighted signal intensity ratios for detection of bowel wall fibrosis in a Crohn’s disease animal model. J Magn Reson Imaging 42:801–810CrossRefPubMedGoogle Scholar
  46. 46.
    Pazahr S, Blume I, Frei P et al (2013) Magnetization transfer for the assessment of bowel fibrosis in patients with Crohn’s disease: initial experience. MAGMA 26:291–301CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • Jonathan R. Dillman
    • 1
    Email author
  • Andrew T. Trout
    • 1
  • Ethan A. Smith
    • 2
  1. 1.Department of RadiologyCincinnati Children’s Hospital Medical CenterCincinnatiUSA
  2. 2.Department of Radiology, University of Michigan Health System, Section of Pediatric RadiologyC.S. Mott Children’s HospitalAnn ArborUSA

Personalised recommendations